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Introduction 
Assessment of patient-reported outcome measures (PROMs) after surgery 
has become an important end-point in clinical trials. Tools in the form of 
questionnaires are vital for evaluating new treatments and procedures as well 
as providing important metrics for a surgeon or unit to document and audit 
their clinical performance. Moreover, repeated evaluation allows recognition 
of changes in patients’ needs that require input from their medical team. 
The BREAST-Q is a questionnaire developed at the Memorial Sloan-
Kettering Cancer Center, USA, to elicit and quantify patient perception of 
outcomes after breast surgery (https://webcore.mskcc.org/breastq) [1]. It 
has been developed using extensive patient input and Rasch psychometric 
methods [2, 3], to measure patient satisfaction and quality of life. Modules 
have been developed for patients undergoing mastectomy, breast 
reconstruction, augmentation, reduction/mastopexy and most recently 
breast-conserving therapy (BCT, wide local excision and radiotherapy). This 
module contains five domains that cover satisfaction with breasts, effect of 
radiotherapy, physical, psychological and sexual wellbeing. There are also 
four domains that focus on satisfaction with the information provided and 
staff interactions. Within each domain, the patient answers multiple sub-
questions according to a Likert scale. To date, there have been nearly one 
hundred publications using the BREAST-Q as an outcome measure. Prior to 
the BCT module being available, researchers modified one of the other 
modules to make it relevant to BCT patients [4], but this strategy did not 
address all the relevant issues. 
To date, there is only one other published study utilising the official 
BREAST-Q BCT module questionnaire, a comparison of the ‘Satisfaction with 
breasts’ domain in patients undergoing BCT with those undergoing 
mastectomy with or without reconstruction. This study demonstrated that 
women who underwent abdominal, buttock or thigh flap reconstruction 
reported a higher breast satisfaction score than those who underwent breast 
conservation, and women who underwent implant reconstruction had the 
lowest satisfaction [5]. The mean or median scores for each of the other 
domains of the BREAST-Q BCT module were not presented in this study. 
The primary aim of our study was to investigate patient satisfaction and 
quality of life after unilateral BCT using the BREAST-Q BCT module. We also 
sought to identify clinical risk factors for women being less satisfied with 
their breast after surgery as reported in the ‘Satisfaction with breasts’ 
domain, and to assess the correlation between the ‘Satisfaction with breasts’ 
domain and the other domains within the BREAST-Q BCT module. 
  
Methods 
Study population 
Research ethical committee approval was obtained (ClinicalTrials.gov 
Identifier: NCT02304614). Women aged ≥18 years who had undergone BCT 
for an invasive or in situ carcinoma between 1 and 6 years before the start of 
the study met the inclusion criteria. Patients who had developed recurrent 
(local or distant) disease since BCT were excluded, as were those who had 
previously or subsequently had surgery to the index or contralateral breast 
and those unable to complete the questionnaire due to learning difficulties or 
a language barrier. 
Eligible patients with mammograms scheduled at a time when the lead 
investigator of the study (ROC) was available to obtain informed consent 
were identified from the hospital database of surveillance mammogram 
bookings. Patients were invited to participate in the study by letter. The 
participants completed the questionnaire anonymously in paper format in a 
quiet room after their planned surveillance mammogram and returned the 
completed questionnaire to an independent member of staff. 
Clinicopathological data were collected from the hospital electronic patient 
record into an electronic case report form. Results from the questionnaire 
were entered into an excel spread sheet (Microsoft Corp., Redmond, 
Washington) independent of the collection of clinicopathological data.  
Data analysis 
Scores were derived for each of the questionnaire’s nine domains. These were 
transformed on a scale of 0–100 according to the BREAST-Q protocol, with a 
higher value representing a more favourable outcome. Analysis was 
undertaken using SPSS (SPSS v22; SPSS, Inc., Chicago). Descriptive 
statistics used included the mean/standard deviation and 
median/interquartile range for parametric and non-parametric data, 
respectively. 
Univariate linear regression analysis was used to identify clinicopathological 
variables which were associated with the ‘Satisfaction with breasts’ score. 
Variables with a p value of less than 0.1 were entered into a multivariate 
model in a forward stepwise manner with a 5 % significance level to identify 
any independent risk factors. 
After testing for normality, Spearman’s rho correlation coefficients were 
calculated between ‘Satisfaction with breasts’ scores and all other domains. 
These were tested with a two-sided 5 % significance level. 
  
Results 
Patient characteristics 
Between 01/04/2015 and 31/10/2015, 649 women were scheduled to have a 
surveillance mammogram. Three hundred and forty two (52.7 %) women 
were eligible for recruitment to the study and had a mammogram booked at a 
time when the investigator was available. All were invited but 109 were not 
contactable by phone to confirm participation. Of the 233 women who were 
contactable, 206 (88.4 %) agreed to participate and 27 (11.6 %) declined. Six 
women who agreed to participate did not attend for their mammogram as 
planned and therefore did not complete the questionnaire. In total, 200 
women completed the questionnaire (Fig. 1). 
 
Fig. 1 
Recruitment to study 
The mean age at time of study was 64.2 years (SD 10.1). 186 women (93 %) 
were of white British origin. The mean body mass index (BMI) was 
27.5 kg/m2 (SD 5.4). Mean time from breast cancer surgery to participation 
in the study was 35.4 months (SD 17.7). Mean ultrasound and mammogram 
sizes were 13.9 mm (SD 8.6) and 16.3 mm (SD 10.88), respectively. Median 
surgical pathology specimen weight was 32.5 g (IQR 20–49). Median time 
from surgery to radiotherapy was 77 days (IQR 66–99.5). 
Patient satisfaction and quality of life after undergoing unilateral BCT as 
reported by the BREAST-Q BCT module 
The scores for each domain within the BREAST-Q BCT module are 
summarised in Table 1. The highest scoring domains were ‘Satisfaction with 
breast surgeon’, ‘Satisfaction with members of medical team’ and 
‘Satisfaction with members of office staff’, all scoring a median of 100 (IQR 
100–100). The lowest scoring domain was ‘sexual wellbeing’, median score 
57 (IQR 45–66). 
 
Table 1 
Results of BREAST-Q BCT module 
Question Number of participants who 
replied to question (n) 
Median 
(IQR) 
Mean 
(SD)a 
Satisfaction with breasts 200 68 (55–80) 69 
(20) 
Effect of radiotherapy 200 89 (78.25–
100) 
84 
(22) 
Psycho-social wellbeing 199 82 (63–100) 78 
(22) 
Sexual wellbeing 125 57 (45–66) 56 (21) 
Physical wellbeing 196 75 (64–86) 76 (18) 
Satisfaction with information 196 77 (64–100) 77 
(22) 
Satisfaction with breast 
surgeon 
197 100 (100–
100) 
91 (18) 
Satisfaction with other 
members of medical team 
199 100 (100–
100) 
93 
(20) 
Satisfaction with other 
members of office staff 
197 100 (100–
100) 
94 
(19) 
aAll of the results were distributed non-parametrically; however, mean and SD 
are displayed to allow comparison with other published literature where the 
mean and SD have been stated 
The median score for Domain 1, ‘Satisfaction with breasts’, was 68 (IQR 55–
80). This was reviewed in more depth by plotting the results for each sub-
question within the domain (Fig. 2). 
 
Fig. 2 
Answers to the sub-questions of the ‘Satisfaction with breasts’ domain. 
Participants answered each sub-question using a Likert scale of very 
dissatisfied to very satisfied 
Identification of clinical risk factors for women being less satisfied with 
their breasts after surgery as reported in the ‘Satisfaction with breasts’ 
domain 
Table 2 shows the clinicopathological features entered into the univariate 
analysis to evaluate risk factors for lower ‘Satisfaction with breasts’. BMI at 
the time of surgery, change in BMI since surgery, type of axillary surgery, 
nodal status, size of tumour on ultrasound (mm), weight of specimen (g) and 
delayed wound healing (>30 days) were risk factors (p < 0.05) for lower 
satisfaction on univariate analysis. BMI at the time of surgery, type of 
axillary surgery and delayed wound healing remained independently risk 
factors on multivariate analysis (Table 3). 
 
Table 2 
Univariate linear regression analyses of ‘Satisfaction with breasts’ from the 
BREAST-Q BCT module 
Variable N Constant (95 % 
CI) 
Coefficient (95 % 
CI) 
pvalue 
Pre-operative data 
Age at surgery (years) 200 69.8 (55.10–
84.56) 
0.00 (−0.24 to 0.25) 0.974 
Ethnic origin   69.8 (67.1–72.6)     
 White 186       
 Non-white 14   3.70 (−14.10 to 6.70) 0.483 
Smoking status   70.2 (66.7–73.6)     
 Never 119       
 Current 16   1.02 (−8.98 to 11.03) 0.840 
 Ex-smoker 65   −2.02 (−7.82 to 3.78) 0.493 
Overall       0.742 
BMI at surgery 196 92.3 (76.8–105.8) −0.83 (−1.31 to 0.35) 0.001* 
Change in BMI from surgery 187 93.2 (79.5–106.8) 0.84 (0.35 to 1.33) 0.001* 
Location of tumour on pre-op 
imaging 
  68.7 (65.1–72.2)     
 Upper Outer 109       
 Central 8   −2.03 (−15.78 to 
11.73) 
0.772 
 Lower inner 27   1.64 (−6.42 to 9.72) 0.688 
 Lower outer 21   7.59 (−1.36 to 16.54) 0.096 
Variable N Constant (95 % 
CI) 
Coefficient (95 % 
CI) 
pvalue 
 Upper Inner 35   −0.03 (−7.32 to 7.27) 0.995 
Overall   –   0.403 
Breast Density   68.3 (64.1–72.5)     
 A 81       
 NA 4   −5.06 (−24.28 to 
14.16) 
0.604 
 B 72   0.62 (−5.46 to 6.70) 0.840 
 C 35   4.35 (−3.24 to 11.94) 0.260 
 D 8   9.82 (−4.09 to 23.72) 0.165 
Overall       0.493 
Mammogram size (mm) 199 71.7 (66.9–76.5) −0.12 (−0.37 to 0.12) 0.315 
Ultrasound size (mm) 198 74.5 (69.4–79.5) −0.36 (−0.67 to 
−0.05) 
0.022* 
Neoadjuvant Therapy   69.8 (67.0–72.6)     
 None 177       
 Endocrine 9   3.51 (−9.30 to 16.33) 0.589 
 Chemo 14   −5.60 (−16.02 to 
4.81) 
0.290 
Overall       0.476 
Intra-operative data 
Surgeon   66.3 (60.8–71.9)     
 Registrar with consultant 
scrubbed 
46       
 Registrar with consultant 
scrubbed 
41   0.55 (−7.52 to 8.63) 0.893 
 Surgeon 1 37   6.64 (−1.65 to 14.9) 0.116 
 Other consultant 35   5.59 (−2.84 to 14.02) 0.193 
Variable N Constant (95 % 
CI) 
Coefficient (95 % 
CI) 
pvalue 
 Surgeon 2 15   2.34 (−8.84 to 13.52) 0.680 
 Surgeon 3 15   3.94 (−7.24 to 15.12) 0.488 
 Surgeon 4 11   8.49 (−4.12 to 21.11) 0.186 
Overall       0.578 
Level of surgeon   71.9 (68.4–75.4)     
 Consultant 113       
 Trainee, supervisor unscrubbed 46   −5.56 (−12.09 to 
0.95) 
0.094* 
 Trainee supervisor scrubbed 41   −5.02 (−11.81 to 1.78) 0.147 
Overall       0.146 
Type of surgery   69.8 (67.0–72.6)     
 WLE 181       
 Other complex 19   −1.87 (−10.9 to 7.19) 0.685 
Axillary surgery   79.5 (71.1–88.0)     
 Nil 19       
 SLNB or sampling 150   −9.80 (−18.76 to 
−0.84) 
0.032 
 ALND 31   −16.71 (−27.44 to 
−6.00) 
0.002 
Overall       0.010* 
Re-excision of margins   70.3 (67.4–73.2)     
 No 169       
 Yes 31   −4.74 (−12.05 to 
−2.57) 
0.203 
Pathology 
Pathology size (mm) 200 72.5 (67.3–77.6) −0.13 (−0.33 to 
−0.07) 
0.199 
Variable N Constant (95 % 
CI) 
Coefficient (95 % 
CI) 
pvalue 
Weight of specimen (g) 200 73.0 (69.4–76.7) −0.08 (−0.14 to 
−0.02) 
0.009* 
Tumour type   69.0 (65.6–72.3)     
 IDC + DCIS 126   0.00   
 IDC 27   −1.35 (−9.29 to 
−6.60) 
0.739 
 DCIS 16   8.34 (−1.61 to 18.28) 0.100 
 Other (including ILC) 31   0.80 (−6.71 to 8.31) 0.834 
Overall       0.384 
Nodal status   70.0 (66.9–73.2)     
 Negative 137   0.00   
 Positive 45   −5.26 (−11.58 to 
−1.06) 
0.102 
Adjuvant therapy 
 Adjuvant chemotherapy   69.9 (67.0–72.9)     
  No 161   0.00   
  Yes 39   −1.75 (−8.45 to 4.95) 0.608 
Endocrine Therapy   73.0 (66.1–79.8)     
 No 30       
 Yes 170   −3.98 (−11.40 to 
3.44) 
0.291 
Timing to first radiotherapy 
fraction 
200 68.3 (65.2–71.4) −0.01 (−0.03 to 
−0.00) 
0.132 
Boost radiotherapy   69.9 (66.9–73.1)     
 No 149       
 Yes 51   −1.55 (−7.64 to 4.54) 0.617 
Post-operative events 
Variable N Constant (95 % 
CI) 
Coefficient (95 % 
CI) 
pvalue 
Infection   70.0 (67.2–72.9)     
 No 171       
 Yes 29   −3.18 (−10.7 to 4.35) 0.405 
Seroma (breast and/or axillary)   69.8 (66.7–72.9)     
 No 144       
 Yes 56   −0.76 (−6.68 to 5.15) 0.799 
Skin necrosis   –   – 
 No 199   –   
 Yes 1       
Haematoma   69.7 (66.9–72.4)     
 No 185       
 Yes 15   −0.99 (−11.08 to 
9.09) 
0.846 
Delayed Wound healing (>30 
days) 
  70.4 (−67.8–73.1)     
 No 192       
 Yes 8   −20.4 (−33.6 to −7.2) 0.003* 
Time from surgery (years) 200 65.9 (60.0–71.8) 0.104 (−0.05 to 0.25) 0.171 
The bold signifies the overall p value 
*p < 0.1 therefore entered into a multivariate model in a forward stepwise 
manner with a 5 % significance level to identify any independent risk factors 
Table 3 
Multivariate linear regression analyses related to ‘Satisfaction with breasts’ 
from the BREAST-Q BCT module 
 Correlation between ‘Satisfaction with breasts’ and all other domains in 
the BREAST-Q BCT module 
There was a statistically significant positive correlation between ‘Satisfaction 
with breasts’ and all of the other domains within the BREAST-Q BCT module 
(Table 4; Fig. 3). However, only ‘Psychological wellbeing’ and ‘Sexual 
wellbeing’ demonstrated a strong correlation; other domains demonstrated 
weak or very weak correlation. 
 
Table 4 
Correlation between different domains of the BREAST-Q questionnaire 
Domain 1 Domain 2 Correlation 
coefficient 
(Spearman’s’ 
rho) 
Interpretation of 
correlation 
Statistical 
significance 
(pvalue) 
Satisfaction 
with breasts 
Effect of 
radiotherapy 
0.302 Weak <0.001 
Satisfaction 
with breasts 
Psycho-social 
wellbeing 
0.606 Strong <0.001 
Satisfaction 
with breasts 
Sexual 
wellbeing 
0.689 Strong <0.001 
Satisfaction 
with breasts 
Physical 
wellbeing 
0.354 Weak <0.001 
Satisfaction 
with breasts 
Satisfaction 
with 
information 
0.288 Weak <0.001 
Satisfaction 
with breasts 
Satisfaction 
with breast 
surgeon 
0.165 Very weak 0.021 
Satisfaction Satisfaction 0.184 Very weak 0.0009 
Domain 1 Domain 2 Correlation 
coefficient 
(Spearman’s’ 
rho) 
Interpretation of 
correlation 
Statistical 
significance 
(pvalue) 
with breasts with medical 
team 
Satisfaction 
with breasts 
Satisfaction 
with office staff 
0.211 Weak 0.003 
Spearman’s correlation coefficient measures the strength of the monotonic 
relationship between paired data and may lie between −1 and 1. 0–0.19 = very 
weak, 0.2–0.39 = weak, 0.4–0.59 = moderate, 0.6–0.79 = strong, 0.8–1 very 
strong 
p < 0.05 is considered a statistically significant correlation 
 
Fig. 3 
Correlation between ‘Satisfaction with breasts’ and the process of care 
domains. aCorrelation between ‘Satisfaction with breasts’ and ‘Satisfaction 
with information given’. bCorrelation between ‘Satisfaction with breasts’ and 
‘Satisfaction with breast surgeon’. cCorrelation between ‘Satisfaction with 
breasts’ and ‘Satisfaction with medical team’. dCorrelation between 
‘Satisfaction with breasts’ and ‘Satisfaction with office staff’  
  
Discussion 
This is the first study reporting complete BREAST-Q results in patients who 
have undergone breast conservation as opposed to mastectomy with or 
without reconstruction. Although Atisha et al. [5] evaluated satisfaction after 
BCT, the mean and median scores for each domain of the BREAST-Q BCT 
module were not reported. Currently, post-operative PROMs are not 
routinely used to measure levels of satisfaction and quality of life in women 
undergoing BCT, despite approximately 2.8 million women living in the USA 
with a current diagnosis or history of breast cancer [6]. In the UK, 
approximately 60 % [7] and in the USA 64.5 % [8] of women with breast 
cancer opt for breast conservation as their surgical treatment. The American 
Society of Plastic Surgeons [9], the UK’s Association of Breast Surgery, the 
British Association of Plastic and Reconstructive and Aesthetic Surgeons and 
the Royal College of Surgeons of England [10] recognise the use of PROMs as 
an end-point in studies and a tool for quality control, and it is widely 
accepted that the aesthetic and functional outcomes after breast cancer 
surgery correlate with higher quality of life [11–13]. 
A mean score of 69 for ‘Satisfaction with breasts’ in our BCT patients is 
higher than that described in the UK National Mastectomy and Breast 
Reconstruction Audit (NMBRA) [10], where, eighteen months after surgery, 
scores were 56 for those undergoing mastectomy alone and 55, 64, 65 and 64 
for immediate reconstruction with implant only, pedicle with implant, 
autologous pedicle flap and free flap, respectively [14]. It might be expected 
that the score for BCT would be higher than mastectomy with reconstruction 
since it is often a day-case procedure with preservation of skin sensation and 
the nipple in most cases. However, it can be argued that women who 
undergoing mastectomy and reconstruction undergo a longer programme of 
care which requires a higher level of patient involvement and decision-
making. Patients who are involved in breast cancer decision-making have 
improved long-term quality of life [15–17], which may also contribute to 
their satisfaction with the appearance of their breasts. 
In our study, the lowest response rate was for ‘Sexual wellbeing’. Only 62.5  % 
of participants completed that domain of the questionnaire. This also had the 
lowest mean score at 56. Other studies using the BREAST-Q in the 
reconstructive setting have also found this domain to have the lowest scores 
[14, 18, 19]. It is well known that women who have been treated for cancer 
may suffer with female sexual dysfunction (FSD) [20]. However, a recent 
prospective study in women one-year post-BCT found no significant 
difference in FSD compared with a healthy control group when using several 
validated questionnaires, though not the BREAST-Q [21]. BREAST-Q ‘Sexual 
wellbeing’ scores vary in the literature ranging from 39.5 [22] to 81.7 [23]. 
Further research into the scores for this domain in women who are not 
undergoing any form of breast surgery (oncological or cosmetic) is required 
to determine whether there is an unmet need in our patients or whether 
these results simply reflect the sexual wellbeing of women in the general 
population. The low response rates may be due to feelings of unease, cultural 
taboo or perceived irrelevance of the domain. 
The BREAST-Q is validated and has been used in many studies, particularly 
in the setting of breast reconstruction [24]. Used over time, or in conjunction 
with the pre-operative baseline questionnaire, changes in an individuals ’ 
satisfaction and quality of life can be identified. It is also possible to compare 
two or more groups of women. The team that developed the BREAST-Q [25] 
has adopted the view of Norman et al. [26] that discrimination for changes, 
that is the minimally important difference, in health-related quality of life for 
chronic diseases appears to be approximately half a standard deviation. 
However, if the questionnaire is used as a one-off assessment, there is not yet 
a body of literature to suggest an acceptable mean or median score for a 
surgeon or clinical unit to use a benchmark, or what may be considered a 
‘satisfied’ or ‘less satisfied’ patient. 
The current literature on risk factors for poor aesthetic outcome after BCT is 
variable in terms of design, size, timing and modality of assessment. The 
most common factors which have been reported to affect the aesthetic 
outcome include BMI [27], age [28–30], ethnic origin [29], menopausal 
status [29], tumour size [29, 31–35], whether the tumour is palpable [36], 
location of the tumour [28, 30, 35, 37, 38], surgical technique [31], specimen 
size/volume [29, 34,36–38], axillary surgery [31], incision/scar [27, 29, 38], 
re-excision [36], post-operative complications [37, 38], type of adjuvant 
radiotherapy [27, 29, 31, 32, 35–37, 39], chemotherapy [27, 29, 33, 35] and 
time since surgery [40]. 
Our multivariate analysis specifically looked at ‘Satisfaction with breasts’ to 
gain a patient perspective rather than an assessment by a panel of clinicians. 
It showed that high BMI, delayed wound healing and type of axillary surgery 
were significant risk factors for lower patient satisfaction score. The ‘cross-
sectional’ study by Atisha et al. [5] also identified high BMI as an 
independent risk factor for lower satisfaction regardless of the procedure 
type. Others have identified high BMI as a risk factor for low satisfaction or 
adverse cosmetic outcome [41] after BCT. It is not possible to assign 
causation as to whether the high BMI truly leads to a worse appearance of 
the breasts after BCT or whether these patients have a poorer body image 
prior to breast cancer surgery which impacts on their evaluation of the post-
treatment appearance. This highlights the importance of obtaining baseline 
data using the pre-operative module of the BREAST-Q to allow a patient’s 
pre-treatment opinion to be assessed and used as a reference point. Delayed 
wound healing is often associated with infection or dehiscence which may 
lead to a more prominent scar. Axillary surgery is a known risk factor for 
breast oedema [42–44] which may in turn lead to swelling, discolouration, 
discomfort and a heavy sensation in the breasts. These factors may lead to 
dissatisfaction with the overall appearance of the breast. 
Age was not a risk factor for lower satisfaction. We believe it is important 
that surgeons appreciate that appearance after surgery is valued by all 
patients regardless of their age. Our findings mirror a previous report that 
there is no correlation between age and breast satisfaction, psycho-social 
well-being nor satisfaction with the outcome in women undergoing post-
mastectomy breast reconstruction [45]. Similarly, patients’ satisfaction 
scores did not vary significantly according to time between surgery and 
answering the questionnaire. Our study included women between 1 and 
6 years from surgery. It could be expected that satisfaction decreases as the 
contralateral breast changes naturally over time [46] and longer-term effects 
of radiotherapy occur [47–49]. Conversely, one might hypothesise that a 
patient may become more satisfied over time as they integrate back into 
‘normal’ life after cancer treatment. Certainly, patients will have changes in  
satisfaction over the course of the breast reconstruction process and 
thereafter [50], however, in the case of BCT, a longitudinal study is required 
to investigate satisfaction over time to help understand this further.  
There were significant positive correlations between ‘Satisfaction with 
breasts’ and all other domains of the BREAST-Q BCT module (Table 4). The 
strongest correlation was with ‘psycho-social wellbeing’ and ‘sexual 
wellbeing’, though any causative effect and its direction remains unclear. The 
correlation with ‘effect of radiotherapy’ and ‘physical wellbeing’ was weaker. 
Regarding the satisfaction with process of care domains (information, breast 
surgeon, medical team and office staff), the scatter graphs demonstrated that 
many women who gave high scores for the patient experience had a more 
varied ‘Satisfaction with breasts’. This indicates that although some women 
have low satisfaction with their breasts after breast cancer treatment, they 
were able to dissociate this with their satisfaction with the process of care 
(Fig. 3). 
The strengths of this study include being the first publication of the full 
dataset for the BREAST-Q BCT module, reporting on a relatively large cohort 
of women. It could be used as a benchmark or comparator for other studies 
until larger national audits have taken place. The multivariate analysis gives 
insight into the factors that affect patient satisfaction and can help guide a 
surgeon in terms of managing expectations. The limitations are the single 
time point evaluation without pre-operative baseline data to understand 
longitudinal changes in patient satisfaction experience during the process of 
BCT and thereafter. Participation bias may be present as a result of the 
14.2 % of the patients who declined to take part in the study and those who 
did not answer particular questions; nevertheless, the completion rate of 
85.8 % of those who were contactable is favourable compared with other 
questionnaire-based studies in the literature. 
  
Conclusion 
Validated questionnaires provide clinicians with a useful insight into their 
patients’ satisfaction. The BREAST-Q is becoming the gold standard and the 
data presented here may serve as a benchmark for future studies. High BMI, 
type of axillary surgery and delayed wound healing are risk factors for lower 
patient satisfaction. ‘Satisfaction with breasts’ is more strongly correlated 
with psycho-social and sexual wellbeing than physical wellbeing or effects or 
radiotherapy. 
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